Track topics on Twitter Track topics that are important to you
Among patients with antineutrophil cytoplasmic antibody-associated vasculitis, changes in BMI and glucocorticoid exposure were linked to improvements in disease activity, according to a published analysis. John H. Stone, MD, MPH, director of clinical rheumatology at Massachusetts General Hospital, and colleagues assessed 197 patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) who participated in the RAVE trial.
Original Article: BMI changes, glucocorticoid exposure improve AAV disease activityNEXT ARTICLE
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...